These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 19962578)
1. Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation. Nahirniak S; Hume HA Transfus Med Rev; 2010 Jan; 24 Suppl 1():S1-6. PubMed ID: 19962578 [No Abstract] [Full Text] [Related]
2. The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline. Shehata N; Palda VA; Meyer RM; Blydt-Hansen TD; Campbell P; Cardella C; Martin S; Nickerson P; Peltekian K; Ross H; Waddell TK; West L; Anderson D; Freedman J; Hume H Transfus Med Rev; 2010 Jan; 24 Suppl 1():S7-S27. PubMed ID: 19962580 [TBL] [Abstract][Full Text] [Related]
3. Indications and safety of intravenous and subcutaneous immunoglobulin therapy. Rezaei N; Abolhassani H; Aghamohammadi A; Ochs HD Expert Rev Clin Immunol; 2011 May; 7(3):301-16. PubMed ID: 21595597 [TBL] [Abstract][Full Text] [Related]
4. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Shehata N; Palda V; Bowen T; Haddad E; Issekutz TB; Mazer B; Schellenberg R; Warrington R; Easton D; Anderson D; Hume H Transfus Med Rev; 2010 Jan; 24 Suppl 1():S28-50. PubMed ID: 19962579 [TBL] [Abstract][Full Text] [Related]
5. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Mawhorter S; Yamani MH Curr Opin Organ Transplant; 2008 Dec; 13(6):581-5. PubMed ID: 19060546 [TBL] [Abstract][Full Text] [Related]
6. Recommended indications for the administration of polyclonal immunoglobulin preparations. Delforge M; Farber CM; Spath P; Kaveri S; Witte T; Misbah SA; Hübner R; Haerynck F; Latinne D; Muylle L; Toungouz M; Deneys V; Acta Clin Belg; 2011; 66(5):346-60. PubMed ID: 22145269 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of certain immune deficient peripheral neuropathies with intravenous immunoglobulins]. Pouget J Rev Prat; 1994 Nov; 44(18):2404-6. PubMed ID: 7855497 [No Abstract] [Full Text] [Related]
13. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia. Cooper N Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436 [TBL] [Abstract][Full Text] [Related]
14. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology]. Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880 [No Abstract] [Full Text] [Related]
15. [Use of intravenous immunoglobulin in neurological disorders]. Steck AJ Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089 [TBL] [Abstract][Full Text] [Related]
16. The evaluation of suspected immune deficiency by the primary care physician. Infante AJ; Kamani NR Compr Ther; 1997 Feb; 23(2):89-94. PubMed ID: 9083718 [No Abstract] [Full Text] [Related]
17. West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin. Saquib R; Randall H; Chandrakantan A; Spak CW; Barri YM Am J Kidney Dis; 2008 Nov; 52(5):e19-21. PubMed ID: 18676077 [TBL] [Abstract][Full Text] [Related]